To validate these findings using vaccine antigens, we immunized H2B-mCherry mice with either SARS-CoV2 receptor binding domain (RBD) or combined tetanus and diphtheria toxoid antigens (Tenivac®) and administered doxycycline on day 10 after vaccination. The gene discussed is H2BC21; the disease is diphtheria.